Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
Clinical trial NCT03207958 · COMPLETED
Trial details
- NCT number
- NCT03207958
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-16
- Primary completion
- 2022-06-04
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.